Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Sarah DavisEmma SimpsonJean HamiltonMarrissa Martyn-St JamesAndrew RawdinRuth WongEdward GokaNeil J GittoesPeter SelbyPublished in: Health technology assessment (Winchester, England) (2021)
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 29. See the NIHR Journals Library website for further project information.